Teaming up to prevent foodborne disease. by Liang, A. P. et al.
Conference Panel Summaries
Vol. 7, No. 3 Supplement, June 2001 Emerging Infectious Diseases 533
Preventing foodborne disease requires the efforts of
different segments of our “global” society. This session
featured presentations on emerging issues across the
spectrum of food safety activities, from science and technology
to policy development and regulation.
Comprehensive Surveillance of Human Caliciviruses
in The Netherlands
Norwalk-like caliciviruses (NLV) are increasingly
recognized as a significant cause of food-related illness. In
recent years, The Netherlands has conducted four NLV
studies: i) a physician-based case-control study, 1996-99; ii) a
population-based cohort study with a nested case-control
design, 1999; iii) NLV testing of stools obtained from patients
who became ill during gastroenteritis outbreaks reported
through municipal health services; and iv) NLV testing in
samples from animal surveillance systems. NLVs were the
causative agent in 5% of patients with foodborne illness seen
by a general practitioner and 16% of patients in the
community cohort. In the past 6 years, NLVs have caused
more than 80% of all gastroenteritis outbreaks. Multiple NLV
variants cocirculate in the population, and their diversity
allows researchers to trace outbreaks to a common source.
Highly related viruses have been found in herds of calves and
swine, suggesting that animals may be a reservoir. A project
has been initiated to study transmission patterns of these
viruses across Europe.
Reducing the Risk of Pathogens in Foods
Under Hazard Analysis and Critical Control Point
(HACCP) systems, food manufacturers identify points where
contamination is likely to occur and implement process
controls to prevent it. A current limitation of the HACCP is
that very few CCP practices are available for on-farm use,
although several interventions appear to have promise. These
practices include probiotic bacteria (benign bacteria that can
be used to out-compete pathogenic bacteria) that prevent
colonization by pathogens, edible vaccines that stimulate IgA
production in an animal’s gut, and improved farm management
practices, such as reducing pathogen contamination in watering
systems. Food processors have a larger array of current and
promising control measures available, but most measures
have limitations. For example, irradiation may cause
undesirable “off” flavors in meat and poultry or undesirable
texture characteristics in vegetables such as lettuce.
Some treatments such as probiotic bacteria may be
especially useful for protecting high-risk populations, such as
the immunocompromised. Inevitably, consumers must also
play a role in preventing foodborne disease. Consumers must
be more active in such practices as avoiding undercooked and
uncooked high-risk foods, refrigerating perishable foods, and
disposing of hazardous foods that have been recalled.
Science as Basis for Regulations
The food industry bears responsibility for providing safe
foods for consumption. A framework of laws, regulations, and
an inspection system facilitates production of safe foods. Food
safety regulations fall into two basic classes: process-based
and performance-based. Future legislative and regulatory
requirements will focus more on performance-based
standards, leaving the specifics of how the standard is
achieved to individual processors, although most will likely
develop HACCP programs. Future regulations, however, will
also consider international agreements, such as those that
enable the World Trade Organization to impose obligations
that nations must fulfill to enter into free trade.
Both international and domestic policy will increasingly
rely on the discipline of risk analysis for decision-making. The
need for better data to conduct risk assessment will spur
increased emphasis on foodborne illness surveillance systems
like FoodNet (1) and PulseNet (2). Results of risk assessments
must be analyzed through the risk management process to
yield food safety policies that lead to development of
performance criteria that the food industry can use to develop
safer food processes.
Borders? What Borders?
There has been a globalization of the food supply.
Although no evidence supports the idea that imported food is
less safe than domestic food, the Food and Drug
Administration’s (FDA) imported foods plan recognizes that
some food safety issues, such as lack of regulatory authority
and basic infrastructure, are specific to developing nations.
Along with important surveillance and sampling activities,
FDA provides international training and fosters technical
cooperation aimed at prevention at the source of production.
FDA’s international partners are often from industry,
nongovernment institutions, and universities. Other key
partners include Food and Agricultural Organization, Pan
American Health Organization, Instituto Interamericano de
Cooperacion para la Agricultura, as well as the Centers for
Disease Control and Prevention and the Foreign Agricultural
Service. In 1999, FDA tested 1,000 samples of imported
celery, cantaloupe, cilantro, green onions, parsley, loose-leaf
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lettuce, strawberries, and broccoli for Salmonella, Shigella,
and  Escherichia coli O157:H7. To date, 95.4% of these
samples have been free of contamination. FDA has worked
closely with several countries (e.g., Costa Rica, Trinidad and
Tobago, Honduras, and Jamaica) to determine their needs
and capacities. Examples of training and outreach include a
Regional Outreach Meeting on Food Safety in Mexico City,
Mexico, and one in Santiago, Chile.
To paraphrase The Future of Public Health, the 1988
Institute on Medicine report, food safety is not just what
government regulators or industry quality assurance managers do.
Food safety is what society does to ensure the conditions under
which people can consume food that is safe, as well as wholesome
and nutritious. Safe food requires the work of producers and
consumers; industry and government; local, state, federal, and,
increasingly, international partners.
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Ethical issues in international research have received an
increasing amount of publicity over the past decade, as more
attention is focused on global health and expanded funding is
provided for research in the developing world. Much of the
discussion has focused on issues that arise when researchers
from countries rich in resources collaborate with researchers
from poorer countries. Some of the controversies result from
research on vaccines and drugs for emerging infectious
diseases. This panel addressed ongoing challenges to
conducting ethical research.
Christine Grady from the National Institutes of Health
reviewed existing international codes and guidelines for
conducting research. Ethical concerns in international
research often stem from the potential for study communities
in the developing world to be vulnerable to exploitation
because of their social and economic circumstances. Several
international codes provide guidance on the ethical conduct of
clinical research including the Declaration of Helsinki,
Council for International Organizations of Medical Sciences
(CIOMS), International Guidelines for Biomedical Research,
and the UNAIDS Guidance Document on Ethical Consider-
ations in HIV Vaccine Research. However, these codes are
recommendations, not legal imperatives. In addition, they do
not address how disagreements might be resolved. Dr. Grady
mentioned some current ethical dilemmas, including
determination of treatment provided to participants during
the course of a clinical trial, the obtaining of informed
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consent, obligations of researchers to the study community,
and investigators’ responsiveness to local health needs.
Although there are no easy answers, she suggested that basic
ethical principles should be applied globally, with local
interpretation and implementation.
Gita Ramjee from the South African Medical Research
Council discussed ethical problems and solutions used by South
African researchers conducting a phase-III trial of a vaginal
microbicide to prevent HIV infection. Researchers realized that
participants did not understand the details of the study.
Investigators then modified the process to include role playing
and to allow time for trial participants to consult with peers.
Researchers also added a knowledge testing component to the
trial. These changes suggest that informed consent is not a one-
time event but is instead an ongoing process.
The need to minimize the risk of participants’ contracting
HIV during the study necessitated an intensive counseling
component. Participants were informed about local HIV
counseling services, and sex workers were encouraged to set
standard prices and to refuse clients who would not use condoms.
This study shows how practical solutions can be used to reduce
risks associated with research.
Finally, Jean Pape from Les Centres GHESKIO in Port-au-
Prince, Haiti, highlighted the major challenges to conducting
international research, which center on obtaining ethical review
or institutional review board clearance.  See page 547 for a more
detailed article concerning this discussion.
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